Silong L. Hu

No. 270, Dong An Road
Shanghai, 200032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Dual-tracer PSMA/FDG PET/CT for lesion detection and risk stratification in biochemical recurrence with negative conventional imaging.

Dual-tracer PSMA/FDG PET/CT for lesion detection and risk stratification in biochemical recurrence with negative conventional imaging.

Journal: European journal of nuclear medicine and molecular imaging

Published: May 25, 2026

Key updates in the 2025 ERS/ATS guideline for the diagnosis of primary ciliary dyskinesia

Key updates in the 2025 ERS/ATS guideline for the diagnosis of primary ciliary dyskinesia

Journal: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases

Published: February 02, 2026

Anti-PD-1 plus nab-paclitaxel and bevacizumab for second-line treatment of cancer of unknown primary (Fudan CUP-002): a phase II trial.

Anti-PD-1 plus nab-paclitaxel and bevacizumab for second-line treatment of cancer of unknown primary (Fudan CUP-002): a phase II trial.

Journal: Nature communications

Published: January 04, 2026

Diagnostic performance of [18F]F-FAPI-FUSCC-07 PET/CT in characterizing solitary pulmonary nodules: a head-to-head comparison.

Diagnostic performance of [18F]F-FAPI-FUSCC-07 PET/CT in characterizing solitary pulmonary nodules: a head-to-head comparison.

Journal: European journal of nuclear medicine and molecular imaging

Published: November 23, 2025

Granzyme B PET/CT predicts chemo-immunotherapy outcomes in microsatellite stable gastric cancers.

Granzyme B PET/CT predicts chemo-immunotherapy outcomes in microsatellite stable gastric cancers.

Journal: European journal of nuclear medicine and molecular imaging

Published: November 17, 2025

Multimodal parameters for the diagnosis of putative primaries of cancer of unknown primary.

Multimodal parameters for the diagnosis of putative primaries of cancer of unknown primary.

Journal: iScience

Published: October 16, 2025

A pilot study of nectin-4-targeted radioligand [68Ga]Ga-FZNR-1 in patients with pancreatic ductal adenocarcinoma: head-to-head comparison with [18F]-FDG.

A pilot study of nectin-4-targeted radioligand [68Ga]Ga-FZNR-1 in patients with pancreatic ductal adenocarcinoma: head-to-head comparison with [18F]-FDG.

Journal: European journal of nuclear medicine and molecular imaging

Published: July 27, 2025

2.5D Deep Learning and Machine Learning for Discriminative DLBCL and IDC with Radiomics on PET/CT.

2.5D Deep Learning and Machine Learning for Discriminative DLBCL and IDC with Radiomics on PET/CT.

Journal: Bioengineering (Basel, Switzerland)

Published: July 02, 2025

Dual-Tracer 18 F-FDG and 68 Ga-PSMA PET/CT Imaging of Heterogeneous Phenotypes of Metastatic Castration-Resistant Prostate Cancer for Predicting Response to Novel Hormone Therapy.

Dual-Tracer 18 F-FDG and 68 Ga-PSMA PET/CT Imaging of Heterogeneous Phenotypes of Metastatic Castration-Resistant Prostate Cancer for Predicting Response to Novel Hormone Therapy.

Journal: Clinical nuclear medicine

Published: November 27, 2024

Pilot Study of Nectin-4-Targeted PET Imaging Agent 68Ga-FZ-NR-1 in Triple-Negative Breast Cancer from Bench to First-in-Human.

Pilot Study of Nectin-4-Targeted PET Imaging Agent 68Ga-FZ-NR-1 in Triple-Negative Breast Cancer from Bench to First-in-Human.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: October 21, 2024

Granzyme B PET/CT Imaging Evaluates Early Response to Immunotherapy in Gastric Cancer.

Granzyme B PET/CT Imaging Evaluates Early Response to Immunotherapy in Gastric Cancer.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: January 29, 2024

The Application of 68Ga-Somatostatin Analog and 18F-FDG PET/CT for Bone Metastasis from Neuroendocrine Tumors.

The Application of 68Ga-Somatostatin Analog and 18F-FDG PET/CT for Bone Metastasis from Neuroendocrine Tumors.

Journal: Neuroendocrinology

Published: January 17, 2024

Showing 1-12 of 47

Last Updated: 09/26/2026